Spruce Biosciences, Inc <SPRB.O>: B. Riley initiates coverage with buy rating; target price $160
SPRB•Related News
U.S. stocks on the move-American Express, Deckers, Q32 Bio
SPY•
Chesapeake Utilities to build $1.2 billion Florida gas pipeline project
CPK•
Press Digest-Canada - July 13
TLT•
Forex-Dollar wavers amid renewed Iran attacks, yen slides on pensions doubts
SPY•
Intel announces $5.7 billion AI-driven capital investment in Ireland
INTC•